Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C
and Chemotherapeutic Agents in Membrane Vesicles
DEMONSTRATION OF GLUTATHIONE-DEPENDENT VINCRISTINE TRANSPORT (*)
- Douglas W. Loe(1),
- Kurt C. Almquist(1)(2)(§),
- Roger G. Deeley(1)(2)(¶) and
- Susan P. C. Cole(1)(2)(**)
- From the (1)Cancer Research Laboratories and
- (2)Department of Pathology, Queen's University, Kingston, Ontario, K7L 3N6 Canada
- ** Career Scientist of the Ontario Cancer Foundation. To whom correspondence and reprint requests should be addressed: Cancer Research Laboratories, Rm. 328, Botterell Hall, Queen's University, Kingston, Ontario, Canada, K7L 3N6. Tel.: 613-545-6507; Fax: 613-545-6830.
Abstract
The 190-kDa multidrug resistance protein (MRP) has recently been associated with the transport of cysteinyl leukotrienes and
several glutathione (GSH) S-conjugates. In the present study, we have examined the transport of leukotriene C
(LTC
) in membrane vesicles from MRP-transfected HeLa cells (T14), as well as drug-selected H69AR lung cancer cells which express
high levels of MRP. V
and K
values for LTC
transport by membrane vesicles from T14 cells were 529 ± 176 pmol mg
min
and 105 ± 31 nM, respectively. At 50 nM LTC
, the K
(ATP) was 70 μM. Transport in T14 vesicles was osmotically-sensitive and was supported by various nucleoside triphosphates
but not by non- or slowly-hydrolyzable ATP analogs. LTC
transport rates in membrane vesicles derived from H69AR cells and their parental and revertant variants were consistent with
their relative levels of MRP expression. A 190-kDa protein in T14 membrane vesicles was photolabeled by [3H]LTC
and immunoprecipitation with MRP-specific monoclonal antibodies (mAbs) confirmed that this protein was MRP. LTC
transport was inhibited by an MRP-specific mAb (QCRL-3) directed against an intracellular conformational epitope of MRP,
but not by a mAb (QCRL-1) which recognizes a linear epitope. Photolabeling with [3H]LTC
was also inhibitable by mAb QCRL-3 but not mAb QCRL-1. GSH did not inhibit LTC
transport. However, the ability of alkylated GSH derivatives to inhibit transport increased markedly with the length of the
alkyl group. S-Decylglutathione was a potent competitive inhibitor of [3H]LTC
transport (K
116 nM), suggesting that the two compounds bind to the same, or closely related, site(s) on MRP. Chemotherapeutic agents
including colchicine, doxorubicin, and daunorubicin were poor inhibitors of [3H]LTC
transport. Taxol, VP-16, vincristine, and vinblastine were also poor inhibitors of LTC
transport but inhibition by these compounds was enhanced by GSH. Uptake of [3H]vincristine into T14 membrane vesicles in the absence of GSH was low and not dependent on ATP. However, in the presence
of GSH, ATP-dependent vincristine transport was observed. Levels of transport increased with concentrations of GSH up to 5
mM. The identification of an MRP-specific mAb that inhibits LTC
transport and prevents photolabeling of MRP by LTC
, provides conclusive evidence of the ability of MRP to transport cysteinyl leukotrienes. Our studies also demonstrate that
MRP is capable of mediating ATP-dependent transport of vincristine and that transport is GSH-dependent.
Footnotes
-
↵§ Supported by an MRCC studentship.
-
↵¶ Stauffer Research Professor of Queen's University.
-
↵* This work was supported in part by a grant from the Medical Research Council of Canada (MRCC) (to S. P. C. C. and R. G. D.).
-
↵1 The abbreviations used are:
- MRP
-
multidrug resistance protein
- AMP-PCP
-
β,
-methyleneadenosine 5′-triphosphate
- AMP-PNP
-
adenosine 5′-[β,
-imido]triphosphate
- ATP
S -
adenosine 5′-O-(3-thiotriphosphate)
- LTC

-
leukotriene C

- LTB

-
leukotriene B

- mAb
-
monoclonal antibody
- VCR
-
vincristine
- PAGE
-
polyacrylamide gel electrophoresis.
-
- Received November 30, 1995.
- Revision received January 17, 1996.
- © 1996 by The American Society for Biochemistry and Molecular Biology, Inc.











